{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:40:17Z","timestamp":1794379217777,"version":"4.9.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C1004141"],"award-info":[{"award-number":["2022R1A2C1004141"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C2011122"],"award-info":[{"award-number":["2022R1A2C2011122"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C1091712"],"award-info":[{"award-number":["2022R1A2C1091712"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor prognosis, largely due to the rapid development of chemoresistance in patients. Mitochondrial dynamics play a crucial role in cancer cell survival. Currently, the specific mechanisms underlying gemcitabine resistance in PDAC remain unknown. In this study, we identified the sodium\/myo-inositol co-transporter solute carrier family 5 member 3 (SLC5A3) as a key modulator promoting chemoresistance in PDAC. SLC5A3 levels were significantly upregulated in gemcitabine-resistant PDAC cells, enhancing their cell survival by stabilizing the mitochondrial functions and inhibiting apoptosis. Mitochondrial analysis showed that SLC5A3 inhibition disrupted the mitochondrial dynamics, leading to increased reactive oxygen species production, mitochondrial fission, and impaired oxidative phosphorylation. Moreover, SLC5A3 inhibition activated the PTEN-induced kinase 1\/Parkin-mediated mitophagy pathway, resulting in the excessive removal of damaged and healthy mitochondria, thereby depleting the mitochondrial reserves and sensitizing the cells to apoptosis. In vivo studies revealed that targeting SLC5A3 enhanced the efficacy of gemcitabine and significantly reduced the tumor growth. Collectively, these results suggest SLC5A3-mediated mitochondrial regulation as a promising therapeutic strategy to overcome gemcitabine resistance in PDAC.<\/jats:p>","DOI":"10.1038\/s41419-025-07476-5","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:37:43Z","timestamp":1741351063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancreatic cancer cells"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5081-2935","authenticated-orcid":false,"given":"Minsoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woosol Chris","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7633-2373","authenticated-orcid":false,"given":"Hyeon Woong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1703-1781","authenticated-orcid":false,"given":"Jae-Ho","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Sol","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wooil","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3514-1247","authenticated-orcid":false,"given":"Hyo Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Seong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"7476_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"7476_CR2","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395:2008\u201320.","journal-title":"Lancet"},{"key":"7476_CR3","doi-asserted-by":"crossref","unstructured":"Koltai T, Reshkin SJ, Carvalho TMA, Di Molfetta D, Greco MR, Alfarouk KO, et al. Resistance to gemcitabine in pancreatic ductal adenocarcinoma: a physiopathologic and pharmacologic review. Cancers (Basel). 2022;14:2486.","DOI":"10.3390\/cancers14102486"},{"key":"7476_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01169-7","volume":"19","author":"C Qin","year":"2020","unstructured":"Qin C, Yang G, Yang J, Ren B, Wang H, Chen G, et al. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Mol Cancer. 2020;19:50.","journal-title":"Mol Cancer"},{"key":"7476_CR5","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1158\/1078-0432.CCR-19-3975","volume":"27","author":"G Yang","year":"2021","unstructured":"Yang G, Guan W, Cao Z, Guo W, Xiong G, Zhao F, et al. Integrative genomic analysis of gemcitabine resistance in pancreatic cancer by patient-derived xenograft models. Clin Cancer Res. 2021;27:3383\u201396.","journal-title":"Clin Cancer Res"},{"key":"7476_CR6","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.2147\/CMAR.S195424","volume":"11","author":"HF Gao","year":"2019","unstructured":"Gao HF, Chen LY, Cheng CS, Chen H, Meng ZQ, Chen Z. SLC5A1 promotes growth and proliferation of pancreatic carcinoma via glucose-dependent AMPK\/mTOR signaling. Cancer Manag Res. 2019;11:3171\u201385.","journal-title":"Cancer Manag Res"},{"key":"7476_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22638-7","volume":"12","author":"HB Low","year":"2021","unstructured":"Low HB, Wong ZL, Wu B, Kong LR, Png CW, Cho YL, et al. DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell death. Nat Commun. 2021;12:2284.","journal-title":"Nat Commun"},{"key":"7476_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202007778","volume":"33","author":"X Guo","year":"2021","unstructured":"Guo X, Yang N, Ji W, Zhang H, Dong X, Zhou Z, et al. Mito-Bomb: targeting mitochondria for cancer therapy. Adv Mater. 2021;33:e2007778.","journal-title":"Adv Mater"},{"key":"7476_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. 2016;166:555\u201366.","journal-title":"Cell"},{"key":"7476_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.849962","volume":"10","author":"DP Boulton","year":"2022","unstructured":"Boulton DP, Caino MC. Mitochondrial fission and fusion in tumor progression to metastasis. Front Cell Dev Biol. 2022;10:849962.","journal-title":"Front Cell Dev Biol"},{"key":"7476_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cmet.2015.06.006","volume":"22","author":"PH Willems","year":"2015","unstructured":"Willems PH, Rossignol R, Dieteren CE, Murphy MP, Koopman WJ. Redox homeostasis and mitochondrial dynamics. Cell Metab. 2015;22:207\u201318.","journal-title":"Cell Metab"},{"key":"7476_CR12","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1158\/0008-5472.CAN-22-2370","volume":"83","author":"Y Li","year":"2023","unstructured":"Li Y, Chen H, Xie X, Yang B, Wang X, Zhang J, et al. PINK1-mediated mitophagy promotes oxidative phosphorylation and redox homeostasis to induce drug-tolerant persister cancer cells. Cancer Res. 2023;83:398\u2013413.","journal-title":"Cancer Res"},{"key":"7476_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther. 2023;8:333.","journal-title":"Signal Transduct Target Ther"},{"key":"7476_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02065-w","volume":"21","author":"Y Guan","year":"2021","unstructured":"Guan Y, Wang Y, Li B, Shen K, Li Q, Ni Y, et al. Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics. Cancer Cell Int. 2021;21:350.","journal-title":"Cancer Cell Int"},{"key":"7476_CR15","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41418-023-01205-1","volume":"30","author":"Y Chen","year":"2023","unstructured":"Chen Y, Jiao D, Liu Y, Xu X, Wang Y, Luo X, et al. FBXL4 mutations cause excessive mitophagy via BNIP3\/BNIP3L accumulation leading to mitochondrial DNA depletion syndrome. Cell Death Differ. 2023;30:2351\u201363.","journal-title":"Cell Death Differ"},{"key":"7476_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06804-5","volume":"15","author":"M Yang","year":"2024","unstructured":"Yang M, Wei X, Yi X, Jiang DS. Mitophagy-related regulated cell death: molecular mechanisms and disease implications. Cell Death Dis. 2024;15:505.","journal-title":"Cell Death Dis"},{"key":"7476_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","volume":"162","author":"A C\u00e9sar-Razquin","year":"2015","unstructured":"C\u00e9sar-Razquin A, Snijder B, Frappier-Brinton T, Isserlin R, Gyimesi G, Bai X, et al. A call for systematic research on solute carriers. Cell. 2015;162:478\u201387.","journal-title":"Cell"},{"key":"7476_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.tibs.2023.05.011","volume":"48","author":"A Schlessinger","year":"2023","unstructured":"Schlessinger A, Zatorski N, Hutchinson K, Colas C. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities. Trends Biochem Sci. 2023;48:801\u201314.","journal-title":"Trends Biochem Sci"},{"key":"7476_CR19","doi-asserted-by":"crossref","unstructured":"Puris E, Fricker G, Gynther M. The role of solute carrier transporters in efficient anticancer drug delivery and therapy. Pharmaceutics. 2023;15:364.","DOI":"10.3390\/pharmaceutics15020364"},{"key":"7476_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.356","volume":"11","author":"Z Wu","year":"2021","unstructured":"Wu Z, Xu J, Liang C, Meng Q, Hua J, Wang W, et al. Emerging roles of the solute carrier family in pancreatic cancer. Clin Transl Med. 2021;11:e356.","journal-title":"Clin Transl Med"},{"key":"7476_CR21","doi-asserted-by":"publisher","first-page":"E3290","DOI":"10.1073\/pnas.1606348113","volume":"113","author":"G Dai","year":"2016","unstructured":"Dai G, Yu H, Kruse M, Traynor-Kaplan A, Hille B. Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P2 levels. Proc Natl Acad Sci USA. 2016;113:E3290\u201399.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7476_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1158\/2159-8290.CD-20-1849","volume":"12","author":"Y Wei","year":"2022","unstructured":"Wei Y, Huang YH, Skopelitis DS, Iyer SV, Costa ASH, Yang Z, et al. SLC5A3-dependent myo-inositol auxotrophy in acute myeloid leukemia. Cancer Discov. 2022;12:450\u201367.","journal-title":"Cancer Discov"},{"key":"7476_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05017-y","volume":"13","author":"Z Cui","year":"2022","unstructured":"Cui Z, Mu C, Wu Z, Pan S, Cheng Z, Zhang ZQ, et al. The sodium\/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth. Cell Death Dis. 2022;13:569.","journal-title":"Cell Death Dis"},{"key":"7476_CR24","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.7150\/ijbs.84570","volume":"19","author":"L Li","year":"2023","unstructured":"Li L, Shen FR, Cheng Q, Sun J, Li H, Sun HT, et al. SLC5A3 is important for cervical cancer cell growth. Int J Biol Sci. 2023;19:2787\u2013802.","journal-title":"Int J Biol Sci"},{"key":"7476_CR25","doi-asserted-by":"crossref","unstructured":"Kim MJ, Kim HS, Kang HW, Lee DE, Hong WC, Kim JH, et al. SLC38A5 modulates ferroptosis to overcome gemcitabine resistance in pancreatic cancer. Cells. 2023;12:2509.","DOI":"10.3390\/cells12202509"},{"key":"7476_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.934746","volume":"13","author":"DE Lee","year":"2022","unstructured":"Lee DE, Kang HW, Kim SY, Kim MJ, Jeong JW, Hong WC, et al. Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction. Front Pharmacol. 2022;13:934746.","journal-title":"Front Pharmacol"},{"key":"7476_CR27","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"7476_CR28","doi-asserted-by":"crossref","unstructured":"Uhlen M, Zhang C, Lee S, Sj\u00f6stedt E, Fagerberg L, Bidkhori G, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357:6352.","DOI":"10.1126\/science.aan2507"},{"key":"7476_CR29","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45:1113\u201320.","journal-title":"Nat Genet"},{"key":"7476_CR30","doi-asserted-by":"crossref","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, et al. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45:580\u20135.","DOI":"10.1038\/ng.2653"},{"key":"7476_CR31","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173:400\u201316.e11.","journal-title":"Cell"},{"key":"7476_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25\u201329.","journal-title":"Nat Genet"},{"key":"7476_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S1470-2045(10)70244-8","volume":"12","author":"LP Jordheim","year":"2011","unstructured":"Jordheim LP, S\u00e8ve P, Tr\u00e9dan O, Dumontet C. The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer. Lancet Oncol. 2011;12:693\u2013702.","journal-title":"Lancet Oncol"},{"key":"7476_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0888-7543(95)80052-N","volume":"25","author":"GT Berry","year":"1995","unstructured":"Berry GT, Mallee JJ, Kwon HM, Rim JS, Mulla WR, Muenke M, et al. The human osmoregulatory Na+\/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21. Genomics. 1995;25:507\u201313.","journal-title":"Genomics"},{"key":"7476_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5616807","volume":"2016","author":"M Bizzarri","year":"2016","unstructured":"Bizzarri M, Dinicola S, Bevilacqua A, Cucina A. Broad spectrum anticancer activity of myo-inositol and inositol hexakisphosphate. Int J Endocrinol. 2016;2016:5616807.","journal-title":"Int J Endocrinol"},{"key":"7476_CR36","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7476_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68510-8","volume":"14","author":"R B\u00f6hme","year":"2024","unstructured":"B\u00f6hme R, Schmidt AW, Hesselbarth N, Posern G, Sinz A, Ihling C, et al. Induction of oxidative- and endoplasmic-reticulum-stress dependent apoptosis in pancreatic cancer cell lines by DDOST knockdown. Sci Rep. 2024;14:20388.","journal-title":"Sci Rep"},{"key":"7476_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13578-016-0103-9","volume":"6","author":"SN Tan","year":"2016","unstructured":"Tan SN, Sim SP, Khoo AS. Potential role of oxidative stress-induced apoptosis in mediating chromosomal rearrangements in nasopharyngeal carcinoma. Cell Biosci. 2016;6:35.","journal-title":"Cell Biosci"},{"key":"7476_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04033-x","volume":"9","author":"GR Anderson","year":"2018","unstructured":"Anderson GR, Wardell SE, Cakir M, Yip C, Ahn YR, Ali M, et al. Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors. Nat Commun. 2018;9:1677.","journal-title":"Nat Commun"},{"key":"7476_CR40","doi-asserted-by":"crossref","unstructured":"Courtois S, de Lux\u00e1n-Delgado B, Penin-Peyta L, Royo-Garc\u00eda A, Parejo-Alonso B, Jagust P, et al. Inhibition of mitochondrial dynamics preferentially targets pancreatic cancer cells with enhanced tumorigenic and invasive potential. Cancers (Basel). 2021;13:698.","DOI":"10.3390\/cancers13040698"},{"key":"7476_CR41","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/npp.2013.194","volume":"39","author":"L Toker","year":"2014","unstructured":"Toker L, Bersudsky Y, Plaschkes I, Chalifa-Caspi V, Berry GT, Buccafusca R, et al. Inositol-related gene knockouts mimic lithium\u2019s effect on mitochondrial function. Neuropsychopharmacology. 2014;39:319\u201328.","journal-title":"Neuropsychopharmacology"},{"key":"7476_CR42","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1016\/j.molcel.2021.08.025","volume":"81","author":"CC Hsu","year":"2021","unstructured":"Hsu CC, Zhang X, Wang G, Zhang W, Cai Z, Pan BS, et al. Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPK. Mol Cell. 2021;81:3803\u201319.e7.","journal-title":"Mol Cell"},{"key":"7476_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1126\/science.aab4138","volume":"351","author":"EQ Toyama","year":"2016","unstructured":"Toyama EQ, Herzig S, Courchet J, Lewis TL Jr., Los\u00f3n OC, Hellberg K, et al. Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science. 2016;351:275\u201381.","journal-title":"Science"},{"key":"7476_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/cpns.105","volume":"94","author":"DJ Rees","year":"2020","unstructured":"Rees DJ, Roberts L, Carla Carisi M, Morgan AH, Brown MR, Davies JS. Automated quantification of mitochondrial fragmentation in an in vitro parkinson\u2019s disease model. Curr Protoc Neurosci. 2020;94:e105.","journal-title":"Curr Protoc Neurosci"},{"key":"7476_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23071-6","volume":"12","author":"EL Giddings","year":"2021","unstructured":"Giddings EL, Champagne DP, Wu MH, Laffin JM, Thornton TM, Valenca-Pereira F, et al. Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance. Nat Commun. 2021;12:2804.","journal-title":"Nat Commun"},{"key":"7476_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06668-9","volume":"15","author":"A Al Assi","year":"2024","unstructured":"Al Assi A, Posty S, Lamarche F, Chebel A, Guitton J, Cottet-Rousselle C, et al. A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity. Cell Death Dis. 2024;15:311.","journal-title":"Cell Death Dis"},{"key":"7476_CR47","doi-asserted-by":"publisher","first-page":"5737","DOI":"10.1111\/febs.15868","volume":"288","author":"RR Koncha","year":"2021","unstructured":"Koncha RR, Ramachandran G, Sepuri NBV, Ramaiah KVA. CCCP-induced mitochondrial dysfunction - characterization and analysis of integrated stress response to cellular signaling and homeostasis. Febs J. 2021;288:5737\u201354.","journal-title":"Febs J"},{"key":"7476_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05103-1","volume":"13","author":"C Chen","year":"2022","unstructured":"Chen C, Zhao S, Zhao X, Cao L, Karnad A, Kumar AP, et al. Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching. Cell Death Dis. 2022;13:682.","journal-title":"Cell Death Dis"},{"key":"7476_CR49","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s12276-020-0390-4","volume":"52","author":"W Li","year":"2020","unstructured":"Li W, Zhu Y, Zhang K, Yu X, Lin H, Wu W, et al. PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer. Exp Mol Med. 2020;52:409\u201322.","journal-title":"Exp Mol Med"},{"key":"7476_CR50","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","volume":"184","author":"L Cao","year":"2021","unstructured":"Cao L, Huang C, Cui Zhou D, Hu Y, Lih TM, Savage SR, et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell. 2021;184:5031\u201352.e26.","journal-title":"Cell"},{"key":"7476_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05345-z","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Chu Y, Li S, Yu L, Deng H, Liao C, et al. The oncoprotein MUC1 facilitates breast cancer progression by promoting Pink1-dependent mitophagy via ATAD3A destabilization. Cell Death Dis. 2022;13:899.","journal-title":"Cell Death Dis"},{"key":"7476_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1470-z","volume":"10","author":"N Yao","year":"2019","unstructured":"Yao N, Wang C, Hu N, Li Y, Liu M, Lei Y, et al. Inhibition of PINK1\/Parkin-dependent mitophagy sensitizes multidrug-resistant cancer cells to B5G1, a new betulinic acid analog. Cell Death Dis. 2019;10:232.","journal-title":"Cell Death Dis"},{"key":"7476_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05711-5","volume":"14","author":"C Qin","year":"2023","unstructured":"Qin C, Wang Y, Zhao B, Li Z, Li T, Yang X, et al. STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation. Cell Death Dis. 2023;14:191.","journal-title":"Cell Death Dis"},{"key":"7476_CR54","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41392-022-01253-y","volume":"7","author":"Y Meng","year":"2022","unstructured":"Meng Y, Qiu L, Zeng X, Hu X, Zhang Y, Wan X, et al. Targeting CRL4 suppresses chemoresistant ovarian cancer growth by inducing mitophagy. Signal Transduct Target Ther. 2022;7:388.","journal-title":"Signal Transduct Target Ther"},{"key":"7476_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04823-8","volume":"13","author":"Y Zhen","year":"2022","unstructured":"Zhen Y, Yuan Z, Zhang J, Chen Y, Fu Y, Liu Y, et al. Flubendazole induces mitochondrial dysfunction and DRP1-mediated mitophagy by targeting EVA1A in breast cancer. Cell Death Dis. 2022;13:375.","journal-title":"Cell Death Dis"},{"key":"7476_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43963-5","volume":"13","author":"IN Boykov","year":"2023","unstructured":"Boykov IN, Montgomery MM, Hagen JT, Aruleba RT, McLaughlin KL, Coalson HS, et al. Pan-tissue mitochondrial phenotyping reveals lower OXPHOS expression and function across cancer types. Sci Rep. 2023;13. 16742.","journal-title":"Sci Rep"},{"key":"7476_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100143","volume":"1","author":"R Masoud","year":"2020","unstructured":"Masoud R, Reyes-Castellanos G, Lac S, Garcia J, Dou S, Shintu L, et al. Targeting mitochondrial complex I overcomes chemoresistance in high OXPHOS pancreatic cancer. Cell Rep. Med. 2020;1:100143.","journal-title":"Cell Rep. Med"},{"key":"7476_CR58","doi-asserted-by":"crossref","unstructured":"Imamura H, Sakamoto S, Yoshida T, Matsui Y, Penuela S, Laird DW, et al. Single-cell dynamics of pannexin-1-facilitated programmed ATP loss during apoptosis. Elife. 2020;9:e61960.","DOI":"10.7554\/eLife.61960"},{"key":"7476_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.854321","volume":"9","author":"B Ebanks","year":"2022","unstructured":"Ebanks B, Chakrabarti L. Mitochondrial ATP synthase is a target of oxidative stress in neurodegenerative diseases. Front Mol Biosci. 2022;9:854321.","journal-title":"Front Mol Biosci"},{"key":"7476_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12929-023-00956-w","volume":"30","author":"SF Wang","year":"2023","unstructured":"Wang SF, Tseng LM, Lee HC. Role of mitochondrial alterations in human cancer progression and cancer immunity. J Biomed Sci. 2023;30:61.","journal-title":"J Biomed Sci"},{"key":"7476_CR61","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ccell.2020.01.007","volume":"37","author":"B Salvador-Barbero","year":"2020","unstructured":"Salvador-Barbero B, \u00c1lvarez-Fern\u00e1ndez M, Zapatero-Solana E, El Bakkali A, Men\u00e9ndez MDC, L\u00f3pez-Casas PP, et al. CDK4\/6 inhibitors impair recovery from cytotoxic chemotherapy in pancreatic adenocarcinoma. Cancer Cell. 2020;37:340\u201353.e6.","journal-title":"Cancer Cell"},{"key":"7476_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06576-y","volume":"15","author":"C Pandini","year":"2024","unstructured":"Pandini C, Pagani G, Tassinari M, Vitale E, Bezzecchi E, Saadeldin MK, et al. The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action. Cell Death Dis. 2024;15:206.","journal-title":"Cell Death Dis"},{"key":"7476_CR63","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1111\/cas.15962","volume":"114","author":"H Masuo","year":"2023","unstructured":"Masuo H, Kubota K, Shimizu A, Notake T, Miyazaki S, Yoshizawa T, et al. Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines. Cancer Sci. 2023;114:4388\u20134400.","journal-title":"Cancer Sci"},{"key":"7476_CR64","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y, et al. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9:124.","journal-title":"Signal Transduct Target Ther"},{"key":"7476_CR65","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fcell.2020.00467","volume":"8","author":"K Ma","year":"2020","unstructured":"Ma K, Chen G, Li W, Kepp O, Zhu Y, Chen Q. Mitophagy, mitochondrial homeostasis, and cell fate. Front Cell Dev Biol. 2020;8:467.","journal-title":"Front Cell Dev Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07476-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07476-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07476-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T13:19:55Z","timestamp":1741353595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07476-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7476"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07476-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study adhered to the ethical guidelines of the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of the Gangnam Severance Hospital (no. 3-2021-0414). Biospecimens (tissues) were collected from the patients with PDAC and individuals with normal pancreas who underwent surgical resection or tissue biopsy at the Gangnam Severance Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"161"}}